Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in...

Area of Science:

• Endocrinology
• Metabolism

Background:

• Thyrotoxicosis is characterized by abnormal growth hormone (GH) secretion patterns, including impaired GH response to growth hormone-releasing hormone (GHRH) and a lack of synergistic response to combined GHRH and GH-releasing peptide-6 (GHRP-6).
• Previous research indicated that reducing circulating triiodothyronine (T3) levels using iopanoic acid enhances the GHRH-induced GH release in thyrotoxic patients.

Purpose of the Study:

• To investigate the effect of decreased serum T3 levels on the combined GH response to GHRP-6 and GHRH in hyperthyroid patients.
• To assess whether reducing T3 levels can normalize the GH response to these peptides in thyrotoxicosis.

Main Methods:

• A study involving 9 hyperthyroid patients and 9 normal subjects.
• Hyperthyroid patients received treatment with iopanoic acid and propylthiouracil for 15 days to decrease serum T3 levels.
• GH response to co-administered GHRP-6 and GHRH was measured before and after treatment.

Main Results:

• Iopanoic acid treatment effectively reduced and normalized serum T3 levels in hyperthyroid patients.
• The combined GH response to GHRP-6 plus GHRH significantly increased after T3 reduction.
• Despite enhancement, the GH response in treated hyperthyroid patients remained significantly lower than in normal subjects.

Conclusions:

• Acute reduction of circulating T3 levels partially enhances the GH response to GHRP-6 plus GHRH in thyrotoxicosis.
• The findings suggest that circulating T3 may not play a critical role in the synergistic mechanism of GHRP-6 and GHRH action.
• Further research is needed to fully elucidate the complex interplay of thyroid hormones and GH regulation.